-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Previous studies of the new coronavirus have shown that the risk of neurological diseases is increased, and anxiety/depressive symptoms may be more common in individuals after SARS-CoV-2 infection
To quantify the relationship between SARS-CoV-2 infection and anxiety/depressive symptoms themselves, it is necessary to separate the consequences of infection from other factors
This study used a large community cohort to assess the prevalence of anxiety/depressive symptoms in individuals with or without SARS-CoV-2 infection
This article was published in the " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry )
The survey data is obtained by the Coronavirus Symptom Research App, a mobile app developed by the health data company Zoe Limited in collaboration with King's College London (KCL), Massachusetts General Hospital, Lund University and Uppsala University
When registering, app users provide demographic and clinical data, including age, height, weight, gender, other diseases (i.
Between February 23, 2021 and April 12, 2021, app contributors are invited to answer a survey on their mental health
The age, gender, body mass index (BMI) group (underweight, overweight, obesity, normal BMI (18.
421977 non-medical workers (aged 18-99, body mass index 15-55) responded to the mental health survey, and 35,827 were positive
Correlation between age, body mass index, comorbidities, learning disabilities, positive SARS-CoV-2 test results and anxiety/depressive symptoms
In general, SARS-CoV-2 infection is associated with anxiety/depressive symptoms
SARS-CoV-2 infection is associated with anxiety/depressive symptoms.
Participant characteristics
In this large community-based study, a positive correlation between SARS-CoV-2 infection and anxiety/depressive symptoms was reported
No association was found between SARS-CoV-2 infection and anxiety/depressive symptoms in the young group (<40 years old)
This suggests that the impact of SARS-CoV-2 on mental health may only be short-lived
Leave a message here